Beijing Chunlizhengda Medical Instruments Co., Ltd. - Laporan Laba Rugi (TTM)

Beijing Chunlizhengda Medical Instruments Co., Ltd.
HK ˙ SEHK ˙ CNE100001TP1
HK$ 17.40 ↑0.80 (4.82%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Beijing Chunlizhengda Medical Instruments Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 913 938 1,007 1,013 984 1,108 1,139 1,197 1,150 1,202 1,191 1,171 1,234 1,209 1,184 1,048 925 806 814 913
Change (%) 2.76 7.35 0.67 -2.92 12.65 2.75 5.12 -3.94 4.51 -0.90 -1.67 5.37 -2.05 -2.03 -11.49 -11.77 -12.85 0.99 12.22
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 263 257 262 252 236 264 258 298 298 302 329 306 333 353 333 314 277 289 308 342
Change (%) -2.23 1.78 -3.66 -6.21 11.72 -2.43 15.71 -0.01 1.14 9.19 -7.07 8.68 6.27 -5.62 -5.74 -11.88 4.46 6.40 10.94
% of Revenue 28.81 27.42 25.99 24.88 24.03 23.83 22.63 24.91 25.93 25.09 27.65 26.13 26.95 29.24 28.16 30.00 29.96 35.91 37.83 37.40
Gross Operating Profit 650 681 745 761 747 844 881 899 852 900 862 865 901 855 851 734 648 516 506 572
Change (%) 4.78 9.45 2.19 -1.83 12.94 4.37 2.02 -5.25 5.69 -4.27 0.39 4.20 -5.12 -0.54 -13.75 -11.72 -20.25 -2.04 13.00
% of Revenue 71.19 72.58 74.01 75.12 75.97 76.17 77.37 75.09 74.07 74.91 72.35 73.87 73.05 70.76 71.84 70.00 70.04 64.09 62.17 62.60
SG&A 275 279 355 323 346 386 400 404 383 443 432 453 449 432 428 376 363 290 284 288
Change (%) 1.39 27.28 -9.06 7.20 11.51 3.87 0.98 -5.18 15.55 -2.50 4.85 -0.94 -3.71 -0.86 -12.21 -3.47 -20.15 -2.01 1.52
% of Revenue 30.12 29.71 35.23 31.83 35.15 34.79 35.17 33.79 33.35 36.87 36.27 38.68 36.36 35.75 36.17 35.88 39.25 35.96 34.89 31.57
R&D 68 73 87 75 86 105 123 143 145 162 162 165 172 157 159 151 142 133 125 116
Change (%) 6.65 20.30 -13.84 13.88 22.35 17.53 15.97 1.24 12.21 0.10 1.31 4.52 -8.50 1.09 -5.42 -5.42 -6.52 -6.08 -6.97
% of Revenue 7.46 7.74 8.68 7.43 8.71 9.46 10.82 11.94 12.58 13.51 13.65 14.06 13.95 13.03 13.44 14.36 15.40 16.52 15.36 12.73
OpEx 611 618 646 652 664 764 792 871 831 920 935 929 981 947 925 854 791 714 719 749
Change (%) 1.19 4.63 0.95 1.84 14.93 3.67 9.98 -4.56 10.74 1.55 -0.56 5.52 -3.41 -2.32 -7.75 -7.36 -9.71 0.74 4.16
% of Revenue 66.90 65.88 64.21 64.39 67.55 68.92 69.53 72.75 72.28 76.59 78.48 79.37 79.48 78.38 78.14 81.45 85.51 88.59 88.37 82.02
Operating Income 302 320 360 361 319 344 347 326 319 281 256 242 253 261 259 194 134 92 95 164
Change (%) 5.93 12.60 0.17 -11.53 7.89 0.72 -5.98 -2.28 -11.73 -8.90 -5.73 4.79 3.21 -0.96 -24.86 -31.12 -31.34 2.94 73.47
% of Revenue 33.10 34.12 35.79 35.61 32.45 31.08 30.47 27.25 27.72 23.41 21.52 20.63 20.52 21.62 21.86 18.55 14.49 11.41 11.63 17.98
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -0.00 9.46 85.43 -9.43 -0.00 -14.28 -10.87 -31.52 -0.00 -0.00
% of Revenue -0.00 -0.00 -0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00
Net Income 264 283 318 322 287 322 328 324 328 308 290 277 279 278 277 231 158 125 128 160
Change (%) 7.38 12.29 1.22 -10.76 12.15 1.72 -1.25 1.27 -6.15 -5.90 -4.40 0.66 -0.29 -0.24 -16.74 -31.38 -21.07 2.30 25.47
% of Revenue 28.92 30.22 31.61 31.79 29.22 29.09 28.80 27.05 28.52 25.61 24.32 23.64 22.58 22.99 23.41 22.02 17.13 15.51 15.71 17.57

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista